Janelle Regier, MD
Rheumatology · Hutchinson, KSNPI 1720297336
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $421 of the $566 with a category attached, or 74.4%. It is spread thinly across 13 manufacturers, the largest accounting for just 23.8%. 2025 is the largest year on record at $199, 6.9 times the $29 reported in 2019. That places this record below the midpoint for rheumatology clinicians in KS, where the typical reported total is $736.
Across 23 payments — averaging $24.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mallinckrodt Hospital Products Inc.$135
- Amgen$83
- Sanofi$76
- Johnson & Johnson$55
- Pfizer$46
- Lilly USA, LLC$29
- plus $143 from 7 others
What the payments were for
- Food & beverage$42174%
- Education$14526%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 3 | $135 |
| Amgen | 2 | $83 |
| Sanofi | 4 | $76 |
| Johnson & Johnson | 1 | $55 |
| Pfizer | 3 | $46 |
| Lilly USA, LLC | 1 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| UCB, Inc. | 1 | $26 |
| E.r. Squibb & Sons, L.L.C. | 1 | $24 |
| GSK | 1 | $24 |
| Organon | 3 | $15 |
| AbbVie | 1 | $13 |
| AstraZeneca | 1 | $12 |
How this compares
$566 in reported general payments places this provider in the 45th percentile of 49 rheumatology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 17 | $231,330 |
| Enbrel SureclickEtanercept | 14 | $99,920 |
| Xeljanz XrTofacitinib Citrate | 12 | $69,981 |
| Hydroxychloroquine Sulfate | 502 | $22,335 |
| Leflunomide | 312 | $18,294 |
| Colchicine | 182 | $13,827 |
| Azathioprine | 196 | $10,084 |
| Mycophenolate Mofetil | 70 | $9,073 |
| Sulfasalazine DrSulfasalazine | 114 | $6,308 |
| MethotrexateMethotrexate Sodium | 273 | $5,805 |
| Cyclosporine | 12 | $3,783 |
| Pilocarpine Hcl | 46 | $3,477 |
| Gabapentin | 134 | $1,745 |
| Prednisone | 210 | $1,609 |
| Duloxetine Hcl | 46 | $1,163 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Hutchinson
- Naveed SalahuddinHutchinson$8K
- Basit MalikHutchinson$736
- James AndersonOverland Park$75K
- Shashank RadadiyaKansas City$74K
- Timothy ShaverWichita$39K
- Stephen RuhlmanOverland Park$32K
- Shadi ShahouriWichita$31K
- Arnold KatzOverland Park$25K
- Aruna BarathamOverland Park$23K
- Kevin LatinisLeawood$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.